Related references
Note: Only part of the references are listed.2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series
Janice Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020
Stephanie Bialek et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients
Andrea T. Obi et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2019)
Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis
Thita Chiasakul et al.
THROMBOSIS RESEARCH (2019)
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
David R. Anderson et al.
BLOOD ADVANCES (2019)
Extended International Normalized Ratio testing intervals for warfarin-treated patients
G. D. Barnes et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Thromboembolism in Pregnancy
Andra James et al.
OBSTETRICS AND GYNECOLOGY (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
Daniel M. Witt et al.
BLOOD ADVANCES (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
Holger J. Schunemann et al.
BLOOD ADVANCES (2018)
Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients
Cheri K. Walker et al.
ANNALS OF PHARMACOTHERAPY (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage A Meta-analysis
Saurav Chatterjee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients
Tzu-Fei Wang et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis
Rick Ikesaka et al.
THROMBOSIS RESEARCH (2014)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients REPLY
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Susan R. Kahn et al.
CHEST (2012)
Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
Clive Kearon et al.
CHEST (2012)
Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios A Randomized Trial
Sam Schulman et al.
ANNALS OF INTERNAL MEDICINE (2011)
Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE
Alex C. Spyropoulos et al.
CHEST (2011)
Factors at Admission Associated With Bleeding Risk in Medical Patients Findings From the IMPROVE Investigators
Herve Decousus et al.
CHEST (2011)
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users
D. M. Witt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
S. Barbar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery
Erin P. Simone et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2008)
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
AT Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Thrombosis risk assessment as a guide to quality patient care
JA Caprini
DM DISEASE-A-MONTH (2005)
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
A Leizorovicz et al.
CIRCULATION (2004)
Share Paper
